Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PTEN mutations in uterine sarcomas.

F Amant1, M de la Rey, C M Dorfling

  • 1Division of Gynecological Oncology, Department of Obstetrics and Gynecology, UZ Gasthuisberg, Leuven, Belgium. Frederic.Amant@uz.kuleuven.ac.be

Gynecologic Oncology
|April 2, 2002
PubMed
Summary

PTEN gene mutations are implicated in the development of uterine carcinosarcomas, particularly those with endometrioid components. These mutations are rarely found in uterine leiomyosarcomas, suggesting distinct molecular pathways for these uterine sarcoma types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surgical stage in the era of molecular profiling of endometrial cancer.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Reply to the Letter to the Editor by Szarpak et al.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Long-term development of 12- and 15-year-old offspring after maternal cancer diagnosis during pregnancy: a prospective multicentre cohort study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Exploring global barriers to optimal ovarian cancer care: thematic analysis.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2025
Same author

Mixed germ cell tumor presenting with mixed sonographic appearance and unique clinical presentation.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Cancer Genetics

Background:

  • Uterine sarcomas encompass carcinosarcomas, leiomyosarcomas, and endometrial stromal sarcomas, with carcinosarcomas being aggressive biphasic tumors.
  • The PTEN tumor suppressor gene is crucial in endometrioid endometrial carcinoma pathogenesis, and chromosome 10q loss of heterozygosity is noted in uterine leiomyosarcoma.
  • Limited knowledge exists regarding the molecular underpinnings of uterine sarcomas, prompting investigation into the PTEN gene's role.

Purpose of the Study:

  • To investigate the potential involvement of the PTEN gene in the carcinogenesis of various uterine sarcoma subtypes.
  • To determine the frequency and significance of PTEN gene mutations in uterine carcinosarcomas, leiomyosarcomas, and endometrial stromal sarcomas.

Main Methods:

Related Experiment Videos

  • Analysis of 21 carcinosarcomas, 21 leiomyosarcomas, and 5 endometrial stromal sarcomas.
  • Utilized exon-by-exon polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis to detect PTEN mutations.

    • Main Results:

    • Somatic PTEN mutations were identified in 8.5% (4/47) of all uterine sarcomas analyzed.
    • PTEN mutations were found in approximately 17% (3/18) of carcinosarcomas with endometrioid components and 5% (1/21) of leiomyosarcomas.
    • No PTEN mutations were detected in carcinosarcomas with non-endometrioid components or in endometrial stromal sarcomas.

    Conclusions:

    • Intragenic PTEN mutations appear to play a role in the development of uterine carcinosarcomas exhibiting endometrioid-type carcinoma features.
    • PTEN mutations are infrequently involved in the pathobiology of uterine leiomyosarcomas, indicating divergent molecular mechanisms.
    • These findings highlight the specific contribution of PTEN alterations in a subset of uterine carcinosarcomas.